Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianxin Hemi'er Gaoziban Anbire Pian
- Development stage
- Unknown
- Lead developer
- 和田维吾尔药业
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jianxin Hemi'er Gaoziban Anbire Pian is a traditional Uyghur medicine developed and manufactured by Hotan Uyghur Pharmaceutical. It is an oral tablet formulation composed of a natural herbal compound mixture. The medicine is primarily indicated for the treatment of palpitations and insomnia accompanied by vivid dreaming. As a traditional multi-herb formulation, its therapeutic effects are attributed to the synergistic action of its various botanical components rather than a single molecular target. It is currently approved and marketed in China as a traditional medicine product.
- Brand names
- 健心合米尔高滋斑安比热片
- Other names
- 健心合米尔高滋斑安比热片
Beyond the preview
Go deeper on Jianxin Hemi'er Gaoziban Anbire Pian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jianxin Hemi'er Gaoziban Anbire Pian.